Spruce Biosciences Inc expected to post a loss of 39 cents a share - Earnings Preview

Spruce Biosciences

12/08/2023 03:04

* Spruce Biosciences Inc  SPRB.OQ   SPRB.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 11
(estimated). 
    * The South San Francisco California-based  company is
expected to
report revenue of $816.67 thousand, according to the mean
estimate from 6 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Spruce Biosciences
Inc is
for a loss of 39 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8​, above​ its last closing price of $2.23.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.33       -0.36      -0.40     Missed  -10.4
 Dec. 31 2023  -0.56       -0.53      -0.47     Beat    11.3
 Sep. 30 2022  -0.54       -0.53      -0.48     Beat    10.3​
 Jun. 30 2022  -0.53       -0.52      -0.51     Beat    2.9
 ​​Mar.        -0.46       -0.46      -0.50     Missed  -9.1
 31 2022                                                
 Dec. 31 2021  -0.54       -0.54      -0.39     Beat    27.8​
 Sep. 30 2021  -0.58       -0.57      -0.49     Beat    14.4
 Jun. 30 2021  -0.45       -0.45      -0.50     Missed  -11.1
 This summary was machine generated August 12 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated